J. Kristie Johnson

8.5k total citations
181 papers, 5.6k citations indexed

About

J. Kristie Johnson is a scholar working on Infectious Diseases, Clinical Biochemistry and Molecular Medicine. According to data from OpenAlex, J. Kristie Johnson has authored 181 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Infectious Diseases, 75 papers in Clinical Biochemistry and 60 papers in Molecular Medicine. Recurrent topics in J. Kristie Johnson's work include Bacterial Identification and Susceptibility Testing (75 papers), Antimicrobial Resistance in Staphylococcus (65 papers) and Antibiotic Resistance in Bacteria (60 papers). J. Kristie Johnson is often cited by papers focused on Bacterial Identification and Susceptibility Testing (75 papers), Antimicrobial Resistance in Staphylococcus (65 papers) and Antibiotic Resistance in Bacteria (60 papers). J. Kristie Johnson collaborates with scholars based in United States, Canada and United Kingdom. J. Kristie Johnson's co-authors include Anthony D. Harris, Kerri A. Thom, Eli N. Perencevich, Jon P. Furuno, Mary‐Claire Roghmann, Graeme N. Forrest, Emily L. Heil, Richard A. Venezia, Daniel J. Morgan and Elizabeth Weekes and has published in prestigious journals such as JAMA, PLoS ONE and Analytical Chemistry.

In The Last Decade

J. Kristie Johnson

178 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Kristie Johnson United States 41 2.4k 2.2k 1.7k 1.5k 991 181 5.6k
Surbhi Malhotra‐Kumar Belgium 34 1.7k 0.7× 2.2k 1.0× 820 0.5× 1.3k 0.8× 784 0.8× 121 5.9k
Teresa Spanu Italy 43 1.4k 0.6× 3.5k 1.6× 1.8k 1.1× 2.3k 1.5× 1.4k 1.4× 130 6.5k
Alan P. Johnson United Kingdom 48 2.5k 1.1× 2.5k 1.1× 1.6k 1.0× 2.5k 1.6× 1.3k 1.4× 231 8.2k
Arti Kapil India 39 1.3k 0.6× 1.9k 0.8× 799 0.5× 1.2k 0.8× 660 0.7× 247 5.1k
Murat Akova Türkiye 39 2.0k 0.8× 2.8k 1.3× 1.1k 0.6× 2.7k 1.8× 894 0.9× 151 6.9k
Irving Nachamkin United States 48 3.4k 1.4× 1.2k 0.5× 857 0.5× 2.0k 1.3× 675 0.7× 195 8.6k
Philippe Lagacé‐Wiens Canada 38 1.3k 0.5× 2.9k 1.3× 982 0.6× 1.7k 1.1× 922 0.9× 126 5.3k
Arne C. Rodloff Germany 38 1.7k 0.7× 1.5k 0.7× 871 0.5× 1.9k 1.3× 435 0.4× 175 5.1k
Karen Lolans United States 33 1.5k 0.6× 2.1k 0.9× 827 0.5× 828 0.6× 725 0.7× 71 4.2k
Heather J. Adam Canada 38 1.3k 0.5× 2.8k 1.3× 1.0k 0.6× 2.1k 1.4× 884 0.9× 144 5.5k

Countries citing papers authored by J. Kristie Johnson

Since Specialization
Citations

This map shows the geographic impact of J. Kristie Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Kristie Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Kristie Johnson more than expected).

Fields of papers citing papers by J. Kristie Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Kristie Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Kristie Johnson. The network helps show where J. Kristie Johnson may publish in the future.

Co-authorship network of co-authors of J. Kristie Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of J. Kristie Johnson. A scholar is included among the top collaborators of J. Kristie Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Kristie Johnson. J. Kristie Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lydecker, Alison D., Justin Kim, Gwen Robinson, et al.. (2025). Chlorhexidine vs Routine Foot Washing to Prevent Diabetic Foot Ulcers. JAMA Network Open. 8(2). e2460087–e2460087. 1 indexed citations
2.
Humphries, Romney M., et al.. (2024). Multicenter evaluation of BioCode GPP for syndromic molecular detection of gastrointestinal pathogens from stool specimens. Journal of Clinical Microbiology. 62(3). e0154523–e0154523. 4 indexed citations
3.
Kent, Alyssa G., Davina Campbell, Mark Burroughs, et al.. (2024). Sentinel Surveillance reveals phylogenetic diversity and detection of linear plasmids harboring vanA and optrA among enterococci collected in the United States. Antimicrobial Agents and Chemotherapy. 68(11). e0059124–e0059124. 5 indexed citations
4.
Claeys, Kimberly C., J. Kristie Johnson, Meghana Patel, et al.. (2024). Improving Antibiotic Use for Ventilator-Associated Pneumonia Through Diagnostic Stewardship: A Proof-of-Concept Mixed Methods Study. Open Forum Infectious Diseases. 11(9). ofae500–ofae500. 1 indexed citations
5.
Smith, Richard D., et al.. (2023). From bottle to bedside: Implementation considerations and antimicrobial stewardship considerations for bloodstream infection rapid diagnostic testing. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(8). 847–863. 4 indexed citations
6.
Lutgring, Joseph D., Alyssa G. Kent, Jolene R. Bowers, et al.. (2023). Comparison of carbapenem-susceptible and carbapenem-resistant Enterobacterales at nine sites in the USA, 2013–2016: a resource for antimicrobial resistance investigators. Microbial Genomics. 9(11). 3 indexed citations
7.
Heil, Emily L., et al.. (2023). Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue Infections. Open Forum Infectious Diseases. 10(12). ofad588–ofad588. 10 indexed citations
8.
Morgan, Daniel J., Erik R. Dubberke, Tiffany Hink, et al.. (2022). The Impact of Universal Glove and Gown Use on Clostridioides Difficile Acquisition: A Cluster-Randomized Trial. Clinical Infectious Diseases. 76(3). e1202–e1207. 7 indexed citations
9.
Simner, Patricia J., Janet A. Hindler, Tanaya Bhowmick, et al.. (2022). What’s New in Antibiograms? Updating CLSI M39 Guidance with Current Trends. Journal of Clinical Microbiology. 60(10). e0221021–e0221021. 17 indexed citations
10.
Yang, Hyojik, Richard D. Smith, Courtney E. Chandler, et al.. (2022). Lipid A Structural Determination from a Single Colony. Analytical Chemistry. 94(21). 7460–7465. 16 indexed citations
11.
Bork, Jacqueline, et al.. (2022). Follow-up Blood Culture Practices for Gram-Negative Bloodstream Infections in Immunocompromised Hosts at a Large Academic Medical Center. Open Forum Infectious Diseases. 9(5). ofac173–ofac173. 11 indexed citations
12.
Smith, Richard D., J. Kristie Johnson, Mark A. Ahlman, et al.. (2021). Clinical evaluation of Sofia Rapid Antigen Assay for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among emergency department to hospital admissions. Infection Control and Hospital Epidemiology. 43(8). 968–973. 14 indexed citations
13.
14.
Claeys, Kimberly C., Richard T. Smith, Yunyun Jiang, et al.. (2021). Day at the Races: Comparing BioFire FilmArray Blood Culture ID Panels With Verigene Blood Culture Panel in Gram-Negative Bloodstream Infections Using DOOR-MAT Analysis. Clinical Infectious Diseases. 73(6). 1103–1106. 11 indexed citations
15.
Claeys, Kimberly C., et al.. (2020). Management of Gram-Negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact With and Without Antibiotic Stewardship. Open Forum Infectious Diseases. 7(10). ofaa427–ofaa427. 25 indexed citations
16.
Vega, Ana, Emily L. Heil, Mary Banoub, et al.. (2020). Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non‐Fulminant Severe Clostridioides difficile Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(5). 398–407. 5 indexed citations
17.
Claeys, Kimberly C., et al.. (2018). Validation of an Antimicrobial Stewardship-Driven Verigene Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics. Open Forum Infectious Diseases. 5(10). ofy233–ofy233. 16 indexed citations
18.
Heil, Emily L. & J. Kristie Johnson. (2016). Commentary: Impact of CLSI Breakpoint Changes on Microbiology Laboratories and Antimicrobial Stewardship Programs. Journal of Clinical Microbiology. 54(4). 840–844. 30 indexed citations
19.
Hazen, Tracy H., Licheng Zhao, Jason W. Sahl, et al.. (2014). Characterization of Klebsiella sp. Strain 10982, a Colonizer of Humans That Contains Novel Antibiotic Resistance Alleles and Exhibits Genetic Similarities to Plant and Clinical Klebsiella Isolates. Antimicrobial Agents and Chemotherapy. 58(4). 1879–1888. 19 indexed citations
20.
Furuno, Jon P., J. Kristie Johnson, Marin L. Schweizer, et al.. (2011). Community-associated Methicillin-resistant Staphylococcus aureusBacteremia and Endocarditis among HIV Patients: A cohort study. BMC Infectious Diseases. 11(1). 298–298. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026